← back to search

Erik W. Thompson

Translational Research Institute ·
Area of research
Oncology · Cancer Research
Research interest
Research interests include Cancer Cells and Metastasis, Protease and Inhibitor Mechanisms, Cell Adhesion Molecules Research, and Cancer Genomics and Diagnostics.
h-index
80
citations
24,667
works
645
NIH funding
primary concept
email

Recent publications

Next‐Generation Oral Ulcer Management: Integrating Cold Atmospheric Plasma (CAP) with Nanogel‐Based Pharmaceuticals for Inflammation Regulation
Advanced Healthcare Materials 2025cited by 12position: middledoi
FlexiPlasma Microcatheter–Embolic Material (FPM‐EM) Platform: A Non‐Inflammatory Pyroptosis Strategy for Precision Hepatocellular Carcinoma Therapy
Small Methods 2025cited by 6position: middledoi
Epidermal growth factor potentiates EGFR(Y992/1173)-mediated therapeutic response of triple negative breast cancer cells to cold atmospheric plasma-activated medium
Redox Biology 2023cited by 27position: lastdoi
Cold atmospheric plasmas target breast cancer stemness via modulating AQP3-19Y mediated AQP3-5K and FOXO1 K48-ubiquitination
International Journal of Biological Sciences 2022cited by 48position: lastdoi
Epithelial-to-Mesenchymal Transition Enhances Cancer Cell Sensitivity to Cytotoxic Effects of Cold Atmospheric Plasmas in Breast and Bladder Cancer Systems
Cancers 2021cited by 62position: lastdoi
In-package plasma: From reactive chemistry to innovative food preservation technologies
Trends in Food Science & Technology 2021cited by 61position: middledoi
Author Correction: Guidelines and definitions for research on epithelial–mesenchymal transition
Nature Reviews Molecular Cell Biology 2021cited by 24position: middledoi
Guidelines and definitions for research on epithelial–mesenchymal transition
Nature Reviews Molecular Cell Biology 2020cited by 2,276position: middledoi
Degradation of cefixime antibiotic in water by atmospheric plasma bubbles: Performance, degradation pathways and toxicity evaluation
Chemical Engineering Journal 2020cited by 203position: middledoi
Controversies around epithelial–mesenchymal plasticity in cancer metastasis
Nature reviews. Cancer 2019cited by 449position: lastdoi
Circulating Tumor Cell cluster phenotype allows monitoring response to treatment and predicts survival
Scientific Reports 2019cited by 62position: middledoi
Prussian blue analogue nanoenzymes mitigate oxidative stress and boost bio-fermentation
Nanoscale 2019cited by 37position: middledoi
Matrix metalloproteinase-9 of tubular and macrophage origin contributes to the pathogenesis of renal fibrosis via macrophage recruitment through osteopontin cleavage
Laboratory Investigation 2013cited by 170position: middledoi
Molecular Profiling of Human Mammary Gland Links Breast Cancer Risk to a p27+ Cell Population with Progenitor Characteristics
Cell stem cell 2013cited by 78position: middledoi

Grants

Supercomputer Initiation: 25 Hours of Supercomputer Time for Elasto-Viscoplastic Analysis
NSF8515109$01985–1986PIRePORTER

Frequent collaborators

Peiyu Wang · Xiamen University7 papers (2019–2025)Renwu Zhou · Xi'an Jiaotong University7 papers (2019–2025)Kostya Ostrikov · Queensland University of Technology6 papers (2019–2023)Rusen Zhou · The University of Sydney5 papers (2020–2025)Xiaofeng Dai · Nanchang University4 papers (2019–2023)Patrick J. Cullen · The University of Sydney3 papers (2019–2021)Liqian Zhao · Wenzhou Medical University3 papers (2021–2025)Elizabeth D. Williams · Prostate Cancer Foundation of Australia2 papers (2019–2021) · 2 papers (2021–2023)Wenshao Li · Flinders University2 papers (2020–2023)Jinyong Lin · Xiamen University2 papers (2023–2025)Anne Mai‐Prochnow · The University of Sydney2 papers (2020–2021)Gang Liu · Université de Lorraine2 papers (2023–2025)Tianqi Zhang · Fudan University2 papers (2020–2021)Chengchao Chu · Xiamen University1 papers (2025–2025)Chia-Hui Lee · National Yang Ming Chiao Tung University1 papers (2023–2023)Guoping Zheng · The University of Sydney1 papers (2013–2013)Zhifa Zhang · Shandong University of Technology1 papers (2022–2022)Frank B. Furnari · University of California San Diego1 papers (2023–2023) · 1 papers (2025–2025)